|
|
Substance Name: Triamcinolone acetonide [USP:INN:BAN:JAN]
RN: 76-25-5
UNII: F446C597KA
InChIKey: YNDXUCZADRHECN-JNQJZLCISA-N
Note
- An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions.
Molecular Formula
- C24-H31-F-O6
Molecular Weight
- 434.5009
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Structure Descriptors
- Toxicity
- Physical Properties
Classification Codes
- Adrenal Cortex Hormones
- Anti-Inflammatory Agents
- Drug / Therapeutic Agent
- Glucocorticoid
- Glucocorticoids
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Human Data
- Immunologic Factors
- Immunosuppressive Agents
- Mutation Data
- Reproductive Effect
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Regulatory Agencies (Superlist Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Triamcinolone acetonide
- Triamcinolone acetonide [USP:INN:BAN:JAN]
MeSH Heading
- Triamcinolone acetonide
Synonyms
- 5-19-06-00568 (Beilstein Handbook Reference)
- 9-alpha-Fluoro-11-beta,21-dihydroxy-16-alpha-isopropylidenedioxy-1,4-pregnadiene,3,20-dione
- 9-alpha-Fluoro-16-alpha-17-alpha-isopropyledenedioxyprednisolone
- 9-alpha-Fluoro-16-alpha-17-alpha-isopropylidenedioxy-delta-1-hydrocortisone
- 9-alpha-Fluoro-16-alpha-hydroxyprednisolone 16-alpha,17-alpha-acetonide
- 9-alpha-Fluoro-16-hydroxyprednisolone acetonide
- 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone
- 9alpha-Fluoro-16-hydroxyprednisolone acetonide
- 9alpha-Fluoro-16alpha-17alpha-isopropyledenedioxyprednisolone
- Acetospan
- Adcortyl A
- AllerNaze
- Aristocort
- Aristocort A
- Aristocort acetonide
- Aristoderm
- Aristogel
- Asmacort [common misspelling of Azmacort]
- Azmacort
- BRN 0060069
- CCRIS 5231
- Coupe-A
- EINECS 200-948-7
- Flutex
- Flutone
- FX006
- Kenacort-A
- Kenalog
- Kenalog 40
- Kenalog in Orabase
- Kenalog-10
- Kenalog-40
- Kenalog-H
- Kenalone
- Nasacort
- Nasacort Allergy 24 Hour
- Nasacort AQ
- Nasacort HFA
- NSC 21916
- Omcilon A
- Oracort
- Oralone
- Panolog Ointment (Veterinary)
- Polcortolon
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11beta,16alpha)-
- Rineton
- Solodelf
- TAC-3
- Tramacin
- Tri-nasal
- Triacet
- Triaceton
- Triacort
- Triam-Injekt
- Triamcincolone acetonide
- Triamcinolone 16,17-acetonide
- Triamcinolone acetonide
- Triamcinolone acetonide in absorbase
- Triamonide 40
- Triamsinolone acetonide
- Trianex
- Triatex
- Tricinolon
- Tricort-40
- Triderm
- Triesence
- Trivaris
- Trymex
- UNII-F446C597KA
- Vetalog
- Vetalog (Veterinary)
- Volon A
- Volon A 40
- Zilretta
Systematic Names
- 9-alpha-Fluoro-11-beta,21-dihydroxy-16-alpha,17-alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11beta,16alpha)-
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,16-alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone
- Triamcinolone acetonide
Mixture Names
- Myco-Triacet II
- Mycolog II
- Mytrex
Registry Numbers
CAS Registry Number
- 76-25-5
FDA UNII
- F446C597KA
Other Registry Numbers
- 13586-95-3
- 138265-06-2
- 8054-16-8
- 911437-91-7
System Generated Number
- 0000076255
Structure Descriptors
InChI
InChI=1S/C24H31FO6/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,25)17(28)11-22(16,4)24(19,31-20)18(29)12-26/h7-9,15-17,19,26,28H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1InChIKey
YNDXUCZADRHECN-JNQJZLCISA-NSmiles
CC1(C)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
man | TDLo | intramuscular | 571ug/kg (0.571mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" VASCULAR: SHOCK | Annals of Pharmacotherpy. Vol. 28, Pg. 1310, 1994. |
mouse | LD50 | intraperitoneal | 105mg/kg (105mg/kg) | Drugs in Japan Vol. 6, Pg. 516, 1982. | |
mouse | LD50 | oral | 5gm/kg (5000mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 21, Pg. 2117, 1979. | |
mouse | LD50 | subcutaneous | 132mg/kg (132mg/kg) | Drugs in Japan Vol. 6, Pg. 516, 1982. | |
rat | LD50 | subcutaneous | 13100ug/kg (13.1mg/kg) | Drugs of the Future. Vol. 6, Pg. 44, 1981. | |
women | TDLo | parenteral | 4mg/kg (4mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION | Netherlands Journal of Medicine. Vol. 56, Pg. 12, 2000. |
Physical Properties
Physical Property | Value | Units | Temp (deg C) | Source |
---|---|---|---|---|
Melting Point | 293 | deg C | EXP | |
log P (octanol-water) | 2.53 | (none) | EXP | |
Water Solubility | 21 | mg/L | 28 | EXP |
Vapor Pressure | 8.25E-14 | mm Hg | 25 | EST |
Henry's Law Constant | 9.83E-13 | atm-m3/mole | 25 | EST |
Atmospheric OH Rate Constant | 8.74E-11 | cm3/molecule-sec | 25 | EST |
Physical property data is provided to ChemIDplus by SRC, Inc.